911爆料网

Page last updated: 3 April 2020.

This page is being updated regularly. Please check back听for the latest information.

COVID-19 procedures are in place for researchers at 911爆料网H.

Read the full statement from UCLH R&D听(updated 3 April听2020)听plus the guidance from the and .

All research studies taking place at 911爆料网H

Please also see our FAQs for researchers (updated 23听March 2020).听
鈥嬧�嬧�嬧�嬧�嬧�嬧�婣ll research activity at 911爆料网H is currently suspended unless the study falls into the priority/permitted categories outlined in the UCLH Research Directorate Covid-19 recommendations. See more.

UCL and UCLH sponsored studies

If your study is sponsored by UCL or UCLH please also review听this guidance.

Studies active at 911爆料网H:

Where sponsors and Principal Investigators have determined a study falls into the priority research categories identified within the UCLH statement,听they should email uclh.randd@nhs.net marking their email with 鈥淐OVID-19 Continuation of Recruitment鈥� providing details of the study: its title, identifier, sponsor and the rationale for continuing recruitment.

Please refer to the attached document听for further guidance from clinical support services regarding managing your study during this period.

Studies not yet active at 911爆料网H:

The Joint Research Office, Clinical Research Facility and Cancer Clinical Trials Unit will continue to review your study but will not issue Decisions to Deliver. Please discuss with sponsors as soon as possible.

Remote monitoring

Where sponsors and Principal Investigators determine a need to request remote access for monitors (in line with the guidance from the HRA, MHRA and UCLH), they should firstly consult the COVID-19 UCLH Remote Monitoring Arrangements guidance document.听Any questions regarding monitoring should be directed to research-incidents@ucl.ac.uk (EpicCare Link specific queries can be directed to uclh.ehrs.researchstudies@nhs.net). This process will be effective from Monday 23rd March 2020.

Frequently Asked Questions

听

听

听